Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cianciosi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Gut|April 1, 1993
Thyroid function and interferon treatment in chronic hepatitis CA Picciotto, G Varagona, P Cianciosi, et al.
Clinical Neuropharmacology|December 1, 1993
Sumatriptan does not affect vasopressin secretion in humansT Barreca, R Franceschini, A Cataldi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Calcitonin and beta-endorphin secretionR Franceschini, A Cataldi, P Cianciosi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Effect of the 5-HT3 receptor antagonist ondansetron on plasma AVP secretion: a study in cancer patientsT Barreca, G Corsini, A Cataldi, et al.
Neuropharmacology|February 1, 1994
The effects of sumatriptan on pituitary secretion in manR Franceschini, A Cataldi, A Garibaldi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failureT Barreca, C Robaudo, A Cataldi, et al.
Stroke|November 1, 1994
Twenty-four-hour beta-endorphin secretory pattern in stroke patientsR Franceschini, C Gandolfo, A Cataldi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Gut|April 1, 1993
Thyroid function and interferon treatment in chronic hepatitis CA Picciotto, G Varagona, P Cianciosi, et al.
Clinical Neuropharmacology|December 1, 1993
Sumatriptan does not affect vasopressin secretion in humansT Barreca, R Franceschini, A Cataldi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Calcitonin and beta-endorphin secretionR Franceschini, A Cataldi, P Cianciosi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Effect of the 5-HT3 receptor antagonist ondansetron on plasma AVP secretion: a study in cancer patientsT Barreca, G Corsini, A Cataldi, et al.
Neuropharmacology|February 1, 1994
The effects of sumatriptan on pituitary secretion in manR Franceschini, A Cataldi, A Garibaldi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failureT Barreca, C Robaudo, A Cataldi, et al.
Stroke|November 1, 1994
Twenty-four-hour beta-endorphin secretory pattern in stroke patientsR Franceschini, C Gandolfo, A Cataldi, et al.
Pageof 1